Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease

Published:2010-01-19 Issue:2 Volume:121 Page:221-229
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Rigotti Nancy A.¹,Pipe Andrew L.¹,Benowitz Neal L.¹,Arteaga Carmen¹,Garza Dahlia¹,Tonstad Serena¹

Affiliation:

1. From the Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (N.A.R.); University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada (A.L.P.); Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine and Bioengineering & Therapeutic Sciences, University of California, San Francisco (N.L.B.); Pfizer Inc, New York, NY (C.A., D.G.); and...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Centers for Disease Control and Prevention US Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/chapters.htm. Accessed January 30 2009.

2. Mortality Risk Reduction Associated With Smoking Cessation in Patients With Coronary Heart Disease

3. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

4. Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease

5. Fiore MC Jaén CR Baker TB Bailey WC Benowitz NL Curry SJ Dorfman SF Froelicher ES Goldstein MG Healton CG Henderson PN Heyman RB Koh HK Kottke TE Lando HA Mecklenburg RE Mermelstein RJ Mullen PD Orleans CT Robinson L Stitzer ML Tommasello AC Villejo L Wewers ME. Treating tobacco use and dependence: 2008 update. clinical practice guideline: U.S. Department of Health and Human Services Public Health Service. Available at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat2.chapter.28163. Accessed March 12 2009.

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tobacco Cessation;APhA OTC - Other Medical Disorders;2024-07

2. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-11

3. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease;Journal of the American College of Cardiology;2024-06

4. The Effect of Varenicline on Smoking Cessation in Hospitalized Patients: A Systematic Review and Meta-Analysis;Addiction and Health;2024-05-01

5. Tobacco Smoking or Nicotine Phenotype and Severity of Clinical Presentation at the Emergency Department (SMOPHED): Protocol for a Noninterventional Observational Study;JMIR Research Protocols;2024-04-24